Altered mucosal bacteria and metabolomics in patients with Peutz-Jeghers syndrome.

Gut Pathog

Department of Gastroenterology, Qilu Hospital of Shandong University, 107 Wenhuaxi Road, Jinan, 250012, Shandong, People's Republic of China.

Published: April 2024

AI Article Synopsis

  • Peutz-Jeghers syndrome (PJS) is a rare genetic disorder that leads to pigmented spots, intestinal polyps, and a higher risk of cancer, with limited research on mucosa-associated microbiota compared to fecal microbiota.
  • * The study analyzed the mucosal microbiota and metabolites in 13 PJS patients and 12 controls using advanced sequencing and mass spectrometry techniques to identify differences in bacterial composition and metabolic pathways.
  • * Results showed that PJS patients had lower bacterial diversity and specific metabolic pathway alterations, suggesting a connection between microbiota disorders and tumor development, marking a significant step in understanding PJS's biological basis.*

Article Abstract

Background: Peutz-Jeghers syndrome (PJS) is a rare genetic disorder characterized by the development of pigmented spots, gastrointestinal polyps and increased susceptibility to cancers. Currently, most studies have investigated intestinal microbiota through fecal microbiota, and there are few reports about mucosa-associated microbiota. It remains valuable to search for the key intestinal microbiota or abnormal metabolic pathways linked to PJS.

Aim: This study aimed to assess the structure and composition of mucosa-associated microbiota in patients with PJS and to explore the potential influence of intestinal microbiota disorders and metabolite changes on PJS.

Methods: The bacterial composition was analyzed in 13 PJS patients and 12 controls using 16S rRNA gene sequencing (Illumina MiSeq) for bacteria. Differential analyses of the intestinal microbiota were performed from the phylum to species level. Liquid chromatography-tandem mass spectrometry (LC‒MS) was used to detect the differentially abundant metabolites of PJS patients and controls to identify different metabolites and metabolic biomarkers of small intestinal mucosa samples.

Results: High-throughput sequencing confirmed the special characteristics and biodiversity of the mucosa microflora in patients with PJS. They had lower bacterial biodiversity than controls. The abundance of intestinal mucosal microflora was significantly lower than that of fecal microflora. In addition, lipid metabolism, amino acid metabolism, carbohydrate metabolism, nucleotide metabolism and other pathways were significantly different from those of controls, which were associated with the development of the enteric nervous system, intestinal inflammation and development of tumors.

Conclusion: This is the first report on the mucosa-associated microbiota and metabolite profile of subjects with PJS, which may be meaningful to provide a structural basis for further research on intestinal microecology in PJS.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11056063PMC
http://dx.doi.org/10.1186/s13099-024-00617-9DOI Listing

Publication Analysis

Top Keywords

intestinal microbiota
16
mucosa-associated microbiota
12
peutz-jeghers syndrome
8
intestinal
8
microbiota
8
patients pjs
8
pjs patients
8
patients controls
8
pjs
7
patients
5

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!